Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in

Mario Delgado1, G Miller Jonakait, Doina Ganea

  • 1Department of Biological Sciences, Rutgers University, Newark, New Jersey 07102, USA.

Glia
|July 12, 2002
PubMed

Insights

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) reduce neuroinflammation by inhibiting microglia-derived chemokines. These neuropeptides limit immune cell infiltration, potentially protecting neurons in CNS disorders.

Area of Science:

  • Neuroimmunology
  • Neuroinflammation
  • Cellular Neuroscience

Background:

  • Microglia are key regulators of central nervous system (CNS) inflammation, releasing chemokines that recruit immune cells.
  • Immune cell infiltration into the CNS is implicated in various neurological diseases.
  • Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are known peripheral anti-inflammatory neuropeptides.

Purpose of the Study:

  • To investigate the effects of VIP and PACAP on chemokine production by activated microglia.
  • To elucidate the molecular mechanisms underlying VIP and PACAP's anti-inflammatory actions in the CNS.

Main Methods:

  • Primary microglia cultures were activated, and the effects of VIP and PACAP on chemokine gene expression were analyzed.
  • NF-kB binding activity was assessed to determine the impact on inflammatory signaling pathways.
  • Chemotactic activity assays were performed to evaluate the functional consequences of VIP/PACAP treatment.

Main Results:

  • VIP and PACAP significantly inhibited the expression of multiple microglia-derived CXC and CC chemokines (MIP-2, KC, MIP-1α, MIP-1β, MCP-1, RANTES).
  • This inhibition of chemokine gene expression correlated with reduced NF-kB binding activity.
  • VIP/PACAP treatment diminished the chemotactic activity of activated microglia for peripheral leukocytes, including neutrophils, macrophages, and lymphocytes.

Conclusions:

  • VIP and PACAP exert potent anti-inflammatory effects on microglia by suppressing chemokine production via a VPAC1 receptor and cAMP-dependent pathway.
  • By reducing immune cell recruitment, VIP and PACAP may act as neuroprotective factors in CNS inflammatory conditions.
  • These findings highlight the therapeutic potential of VIP and PACAP in managing neuroinflammatory and neurodegenerative diseases.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Hormonal Regulation02:03

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.The ProcessStarting in the stomach, when proteins are detected by sensory neurons of the enteric nervous system, the pyloric gland is stimulated to release gastrin. In turn, this hormone induces the release of histamine. Combined, they...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...